Litcius/Paper detail

Double-Blind Placebo-Controlled Randomized Clinical Trial of Neurofeedback for Attention-Deficit/Hyperactivity Disorder With 13-Month Follow-up

L. Eugene Arnold, Martijn Arns, Justin A. Barterian, Rachel Bergman, Sarah R. Black, C. Keith Conners, Shea Connor, Sudeshna Dasgupta, Roger deBeus, Teryll Higgins, Laurence Hirshberg, Jill A. Hollway, Cynthia Kerson, Howard Lightstone, Nicholas Lofthouse, Joel F. Lubar, Keith McBurnett, Vincent J. Monastra, Kristin A. Buchan-Page, Xueliang Pan, Robert R. Rice, Michelle E. Roley‐Roberts, Rachel Rhodes, Constance Schrader, Yubo Tan, Craig Williams

2020Journal of the American Academy of Child & Adolescent Psychiatry122 citationsDOIOpen Access PDF

Topics & Concepts

NeurofeedbackAttention deficit hyperactivity disorderRandomized controlled trialPlaceboPsychologyClinical Global ImpressionBlindingAdverse effectMedicinePhysical therapyAudiologyPediatricsPsychiatryInternal medicineElectroencephalographyAlternative medicinePathologyAttention Deficit Hyperactivity DisorderNeural and Behavioral Psychology StudiesFunctional Brain Connectivity Studies
Double-Blind Placebo-Controlled Randomized Clinical Trial of Neurofeedback for Attention-Deficit/Hyperactivity Disorder With 13-Month Follow-up | Litcius